Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: Mortality prognostic study

Critical Care Medicine

Volumn 28, Issue 1, 2000, Pages 57-62

  Amat, Mercè ^c   Barcons, Miquel ^c   Mancebo, Jordi ^c   Mateo, José ^c   Oliver, Artur ^a   Mayoral, Juan Francisco ^a   Fontcuberta, Jordi ^c   Vila, Luis ^b  

^a FUNDACIÓ PUIGVERT   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c NONE

Author keywords

Acute respiratory distress syndrome; Interleukin 8; Leukotriene B4; Leukotriene C4; Leukotriene D4; Mortality; Pep tide leukotrienes; Plasma; Prognosis

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; PEPTIDE; LEUKOTRIENE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ICOSANOID METABOLISM; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; INTENSIVE CARE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RISK; RISK FACTOR; STATISTICAL MODEL;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTENSIVE CARE; INTERLEUKIN-8; LEUKOTRIENES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS;

EID: 0033629773     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200001000-00009     Document Type: Article

References (37)

1. 1. Murray JF, Mathay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
2. 2. MacNaughton PD, Evans TW: Management of adult respiratory distress syndrome. Lancet 1992; 339:469-472
3. 3. Weiland JE, Davis WB, Holter JF, et al: Lung neutrophils in the adult respiratory distress syndrome. Am Rev Respir Dis 1986; 133: 218-225
4. 4. Ognibene FP, Martin SE, Parker MM, et al: Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 1986; 315:547-551
5. 5. Martin TR, Pistorese BP, Hudson LD, et al: The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 144:254-262
6. 6. Stephenson AH, Lonigro AJ, Hyers TM, et al: Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis 1988; 138:714-719
7. 7. Ratnoff WD, Matthay MA, Wong MYS, et al: Sulfidopeptide-leukotriene peptidases in pulmonary edema fluid from patients with the adult respiratory distress syndrome. J Clin Immunol 1988; 8:250-258
8. 8. Schönfeld W, Knöller J, Joka T, et al: Leukotriene generation in patients with multiple injuries. J Trauma 1992; 33:799-806
9. 9. Antonelli M, Raponi G, Lenti L, et al: Leukotrienes and alpha tumor necrosis factor levels in the bronchoalveolar lavage fluid of patient at risk for the adult respiratory distress syndrome. Minerva Anestesiol 1994; 60:419-426
10. 10. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146:427-432
11. 11. Chollet-Martin S, Montravers P, Cibert C, et al: High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 1993; 61:4553-4559
12. 12. Meduri GU, Kohler G, Headley S, et al: Inflammatory cytokines in the BAL of patients with ARDS: Persistent elevation over time predicts poor outcome. Chest 1995; 108:1303-1314
13. 13. Donnelly SC, Strieter RM, Kunkel SL, et al: Interleukin-8 and development of adult respiratory distress syndrome in at risk patient groups. Lancet 1993; 341:643-647
14. 14. Verra F, Hmouda H, Rauss A, et al: Bronchoalveolar lavage in immunocompromised patients: Clinical and functional consequences. Chest 1992; 101:1215-1220
15. 15. Goldstein RA, Rohatgi PK, Bergofsky EH, et al: Clinical role of bronchoaiveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 1990; 142:481-486
16. 16. Rivkind AI, Siegel JH, Guadalupi P, et al: Sequential patterns of eicosanoid, platelet, and neutrophil interactions in the evolution of the fulminant post-traumatic adult respiratory distress syndrome. Ann Surg 1989; 210:355-372
17. 17. Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107:1062-1073
18. 18. Hack CE, Hart M, Strack van Schijndel RJM, et al: Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infect Immun 1992; 60:2835-2842
19. 19. Danner RL, Suffredini AF, Van Dervort AL: Detection of interleukin 6 (IL-6) and interleukin 8 (IL-8) during septic shock in humans. Clin Res 1990; 38:352A
20. 20. Le Gall JR, Loirat P, Alperovitch A, et al: A simplified adult physiology score for ICU patients. Crit Care Med 1984; 12:975-977
21. 21. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Am J Respir Crit Care Med 1994; 149: 818-824
22. 22. Hudson LD, Milberg JA, Anardi D, et al: Clinical risks for development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:293-301
23. 23. Mathews WR, Rokach J, Murphy RC: Analysis of leukotrienes by high pressure liquid chromatography. Anal Biochem 1981; 118:96-101
24. 24. Roupie E, Lepage E, Brochard L, et al: Incidence and outcome of adult respiratory distress syndrome (ARDS) among hypoxemic ventilated patients. Intensive Care Med 1997; 23(Suppl 1):S112
25. 25. Stewart TE, Meade MO, Cook DJ, et al: Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for adult respiratory distress syndrome. N Engl J Med 1998; 338:355-361
26. 26. Kleinbaum DG, Kupper LL, Morgenstern H: Modeling: Theoretical considerations. In: Epidemiologic Research: Principles and Quantitative Methods. Kleinbaum DG, Kupper LL, Morgenstern H (Eds). New York, Van Nostrand Reinhold, 1982, pp 419-446
27. 27. Shindo K, Matsumoto Y, Sumitomo M, et al: Measurement of leukotriene C4 and D4 in arterial blood of asthmatic patients during remission. Ann Allergy 1991; 66:405-410
28. 28. Bernard GR, Korley V, Chee P, et al: Persistent generation of peptido leukotrienes in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1991; 144:263-267
29. 4 excretion in patients with ARDS and severe burns. Prostaglandins Leukot Essent Fatty Acids 1991; 43:151-158
30. 30. Fauler J, Tsikas D, Holch M, et al: Enhanced synthesis of cysteinyl leukotrienes in polytraumatized patients with and without adult distress syndrome. Clin Res 1990; 38:2A
31. 31. Meduri GU, Belenchia JM, Estes RJ, et al: Fibroproliferative phase of ARDS: Clinical finding and effects of corticosteroids. Chest 1991; 100:943-952
32. 4-receptor antagonist in endotoxin shock: A prospective, controlled trial in a porcine model. Crit Care Med 1993; 21: 1825-1837
33. 33. Ishizaka A, Hasegawa N, Sakamaki F, et al: Effects of ONO-1078, a peptide leukotriene antagonist, on endotoxin-induced adult lung injury. Am J Respir Crit Care Med 1994; 150:1325-1331
34. 34. Williams JG, Maier RV: Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in adult lung injury (adult respiratory distress syndrome). Surgery 1992; 112:270-277
35. 35. Yu M, Tomasa G: A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993; 21:1635-1642
36. 36. Zakrewski JT, Sampson AP, Evans JM, et al: The biotransformation in vitro of cysteinyl leukotrienes in blood of normal and asthmatic subjects. Prostaglandins 1989; 35:425-444
37. 4 in sepsis. Res Commun Chem Pathol Pharmacol 1994; 83:151-156